In 1997, Harry H. Zhabilov completed his Masters in Bulgaria at the University of Chemical Technology and Metallurgy in Sofia. Presently, Harry H. Zhabilov occupies the position of Chief Scientific Officer at Enzolytics, Inc., Chief Scientific Officer for Immunotech Laboratories, Inc. Mr. Zhabilov is also a Member of American Chemical Society and a Member of American Institute of Chemical Engineers. In his past career, Mr. Zhabilov held the position of Chief Scientific Officer for GXP Biopharm, Inc., and Vice President of Research and Development for Viral Genetics, Inc.
Mr. Zhabilov has long-term experience in protein isolation and purification in immunochemistry and biochemistry along with experience in Experience with therapeutic proteins used in HIV and cancer. Harry Zhabilov also possess experience in the preparation of an application for a nutraceutical compound/supplement for the FDA. Mr. Zhabilov is also the inventor of several U.S. patents which are related to the immunotherapy of HIV and cancer and acts as an immune enhancer based on the IPF platform. Furthermore, Mr. Zhabilov has also participated in several clinical trials utilizing therapeutic proteins.
TICKER SYMBOL: ENZC
Copyright © 2020 Enzolytics, Inc. - All Rights Reserved.